- Home
- Publications
- Publication Search
- Publication Details
Title
The pridopidine paradox in Huntington's disease
Authors
Keywords
-
Journal
MOVEMENT DISORDERS
Volume 28, Issue 10, Pages 1321-1324
Publisher
Wiley
Online
2013-07-11
DOI
10.1002/mds.25559
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A randomized, double-blind, placebo-controlled trial of pridopidine in Huntington's disease
- (2013) MOVEMENT DISORDERS
- Physical therapy in Huntington's disease - toward objective assessments?
- (2012) S. Bohlen et al. EUROPEAN JOURNAL OF NEUROLOGY
- The dopamine stabilizers ACR16 and (−)-OSU6162 display nanomolar affinities at the σ-1 receptor
- (2012) K Sahlholm et al. MOLECULAR PSYCHIATRY
- Huntington's disease: Objective assessment of posture-A link between motor and functional deficits
- (2012) Ralf Reilmann et al. MOVEMENT DISORDERS
- Pridopidine in treatment of Huntington's disease: beyond chorea?
- (2011) Andrew Feigin LANCET NEUROLOGY
- Pridopidine for the treatment of motor function in patients with Huntington's disease (MermaiHD): a phase 3, randomised, double-blind, placebo-controlled trial
- (2011) Justo Garcia de Yebenes et al. LANCET NEUROLOGY
- Potential endpoints for clinical trials in premanifest and early Huntington's disease in the TRACK-HD study: analysis of 24 month observational data
- (2011) Sarah J Tabrizi et al. LANCET NEUROLOGY
- Pharmacologic approaches to the treatment of Huntington's disease
- (2011) Charles S. Venuto et al. MOVEMENT DISORDERS
- Analysis of the actions of the novel dopamine receptor-directed compounds (S)-OSU6162 and ACR16 at the D2 dopamine receptor
- (2010) Elodie Kara et al. BRITISH JOURNAL OF PHARMACOLOGY
- Efficacy and Safety of the Dopaminergic Stabilizer Pridopidine (ACR16) in Patients With Huntington's Disease
- (2010) Anders Lundin et al. CLINICAL NEUROPHARMACOLOGY
- In vivo pharmacology of the dopaminergic stabilizer pridopidine
- (2010) Henrik Ponten et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Grasping premanifest Huntington's disease - shaping new endpoints for new trials
- (2010) Ralf Reilmann et al. MOVEMENT DISORDERS
- Fall risk assessment using the Tinetti mobility test in individuals with Huntington's disease
- (2010) Anne D. Kloos et al. MOVEMENT DISORDERS
- Tapping in Huntington disease: A path forward to preventive therapies?
- (2010) K. M. Biglan NEUROLOGY
- Tapping linked to function and structure in premanifest and symptomatic Huntington disease
- (2010) N. Bechtel et al. NEUROLOGY
- The dopaminergic stabilizers pridopidine (ACR16) and (−)-OSU6162 display dopamine D2 receptor antagonism and fast receptor dissociation properties
- (2009) Tino Dyhring et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data
- (2009) Sarah J Tabrizi et al. LANCET NEUROLOGY
- The dopaminergic stabilizer ASP2314/ACR16 selectively interacts with D2Highreceptors
- (2009) Philip Seeman et al. SYNAPSE
- Mobility and falls in people with Huntington's disease
- (2008) M. E. Busse et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now